Maximize the benefits of INR self-testing

ACH self-testing services exhibited higher TTR results when compared to lab and point of care1

Maximize the
benefits of INR
self-testing

ACH self-testing services
exhibited higher TTR results
when compared to lab and
point of care1

Acelis connected health INR self-testing demonstrated:

Promo 1

42%

Fewer
thromboembolic
events

Have been associated
with patient self-testing.2

Promo 2

70%

Time in
therapeutic
range

Versus 63% with POC
and 55% with Lab.3

Promo 3

95%

Overall
patient
satisfaction

With scores for “easy to use”
and “peace of mind.”4

A complete program that benefits patients and clinicians

Comprehensive coverage and support—including industry-leading 70% TTR vs. 66% PST industry averages5, plus the ability to service 70% of lives under managed care.

Connected RPM tools

When patients use our HealthCheck app, they have the ability to report results and order supplies. Our CoagClinic™ Remote Patient Monitoring platform enables clinicians to send test reminders, review patient results and track trends.

Convenient services and supplies

Including digital prescriptions that showed 25% less follow-up and 30% faster prescription processing,6 plus customer support, testing reminders and easy access to services and information.

* Over the course of an entire year; separate independent studies.
1: Acelis Connected Health internal data on file.
2: Bloomfield et al. Meta-analysis: Effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes.
3: CHEST 2005; 127:1515–1522
4: Acelis Connected Health internal data on file.
5: Internal ACH data on file. The TTR results shown are the average of patient test results from 1-1-19 to 12-31-19. CHEST 2005;127:1515–152
6: Based on ACH eRx and paper prescriptions submitted from May 2020 to August 19, 2020.

Looking for more details?

Download our INR brochure and Rx form

To learn more and share with your physician 

or 877.262.4669